| 3L16: Discovery Of (Thienopyrimidin-2-Yl)Aminopyrimidines As Poten Selective, And Orally Available Pan-Pi3-Kinase And Dual Pan Kinasemtor Inhibitors For The Treatment Of Cancer reference: Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer., Sutherlin DP, Sampath D, Berry M, Castanedo G, Chang Z, Chuckowree I, Dotson J, Folkes A, Friedman L, Goldsmith R, Heffron T, Lee L, Lesnick J, Lewis C, Mathieu S, Nonomiya J, Olivero A, Pang J, Prior WW, Salphati L, Sideris S, Tian Q, Tsui V, Wan NC, Wang S, Wiesmann C, Wong S, Zhu BY, J Med Chem. 2010 Feb 11;53(3):1086-97. PMID: 20050669 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).